Sort by 'likes'
Role of Allogeneic Stem Cell Transplant in Myeloma Treatment with Dr. Krishna Komanduri
The role of allogeneic stem-cell transplantation is evolving in the paradigm of myeloma treatment. Despite its therapeutic potential of a myeloma cure, the use of donor stem cell transplantation is highly debated in the medical field due to the safety…
Nonsecretory Multiple Myeloma: New Options in Assessment and Treatment
Hallmark of most multiple myeloma cases is the persistent production of some form of immunoglobulins, a phenomenon that brings the disease to attention. However, there is a subset of multiple myeloma patients who do not secrete immunoglobulin or its component…
Risk Stratfiied Treatment and Active Surveillance in Prostate Cancer
Should you opt for active surveillance when diagnosed with prostate cancer or Does your PSA test warrant more aggressive therapy instead? Tune in to hear Dr.Matthew Cooperberg’s views on the controversial PSA testing and hear him talk about treatments based…
Using Clinical Data to Determine Treatments in Myeloma
Using Clinical Trial Data to Determine Treatment Options, has been successfully implemented by Dr. McCarthy and team and here he discusses the various preclinical new drug developments for myeloma treatment
Osteonecrosis of the Jaw & Myeloma with Dr. John Killip – On-Air Myeloma Support Group
Osteonecrosis of the Jaw (ONJ) is a condition associated with a loss of blood supply to the jaw, causing the jawbone tissue death. Although the prevalence of ONJ is below 1%, it is more common in multiple myeloma patients as…